Company / Capital Returned to Shareholders per Share
NovoCure Ltd Capital Returned to Shareholders per Share History
FY2016-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.00
FY2017
5-year range
-
FY2016-FY2017
Trend
-3.8%
vs FY2016
Sector context
#96 of 108
Health Care
What the data says
NovoCure Ltd's capital returned to shareholders per share of $0.00 is lower than 89% of companies in the Health Care sector (FY2017).
Based on SEC 10-K filings.
0.00 in FY2017.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 108This company $0.00 Sector average $4.89
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2017, capital returned to shareholders per share decreased 3.8% year-over-year.
- Ranks #96 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | $0.00 | -3.8% |
| FY2016 | $0.00 | -84.0% |
As of FY2017 · SEC 10-K · Updated Jun 30, 2026